ERBB2 and breast carcinoma: While breast cancers with only positive steroid receptors showed just mild zinc elevations, zinc increased with the expression of the Her2 receptor, thus being higher in HRneg/Her2-positive and even higher in triple-positive (HRpos/Her2pos) breast cancers.